Ligand Pharmaceuticals (LGNYZ) Long-Term Debt Issuances (2019 - 2022)
Historic Long-Term Debt Issuances for Ligand Pharmaceuticals (LGNYZ) over the last 5 years, with Q3 2022 value amounting to $202000.0.
- Ligand Pharmaceuticals' Long-Term Debt Issuances fell 9030.24% to $202000.0 in Q3 2022 from the same period last year, while for Dec 2024 it was $202000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $202000.0 for FY2022, which is 9893.34% down from last year.
- Ligand Pharmaceuticals' Long-Term Debt Issuances amounted to $202000.0 in Q3 2022, which was down 9030.24% from $2.1 million recorded in Q3 2021.
- Over the past 5 years, Ligand Pharmaceuticals' Long-Term Debt Issuances peaked at $16.9 million during Q1 2021, and registered a low of $202000.0 during Q3 2022.
- Its 3-year average for Long-Term Debt Issuances is $7.9 million, with a median of $7.2 million in 2019.
- Over the last 5 years, Ligand Pharmaceuticals' Long-Term Debt Issuances had its largest YoY gain of 9030.24% in 2022, and its largest YoY loss of 9030.24% in 2022.
- Quarter analysis of 3 years shows Ligand Pharmaceuticals' Long-Term Debt Issuances stood at $12.4 million in 2019, then plummeted by 83.2% to $2.1 million in 2021, then crashed by 90.3% to $202000.0 in 2022.
- Its Long-Term Debt Issuances was $202000.0 in Q3 2022, compared to $2.1 million in Q3 2021 and $16.9 million in Q1 2021.